FibroBiologics/$FBLG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About FibroBiologics
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
Ticker
$FBLG
Sector
Health
Primary listing
Employees
13
Headquarters
Website
FibroBiologics Metrics
BasicAdvanced
$22M
-
-$0.37
-
-
Price and volume
Market cap
$22M
52-week high
$3.70
52-week low
$0.53
Average daily volume
596K
Financial strength
Current ratio
0.928
Quick ratio
0.807
Long term debt to equity
242.209
Total debt to equity
1,253.023
Interest coverage (TTM)
-1,462.18%
Profitability
EBITDA (TTM)
-15.886
Management effectiveness
Return on assets (TTM)
-88.11%
Return on equity (TTM)
1,731.89%
Valuation
Price to book
25.38
Price to tangible book (TTM)
25.38
Price to free cash flow (TTM)
-1.248
Free cash flow yield (TTM)
-80.15%
Free cash flow per share (TTM)
-0.428
Growth
Earnings per share change (TTM)
-42.85%
What the Analysts think about FibroBiologics
Analyst ratings (Buy, Hold, Sell) for FibroBiologics stock.
FibroBiologics Financial Performance
Revenues and expenses
FibroBiologics Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for FibroBiologics stock?
FibroBiologics (FBLG) has a market cap of $22M as of August 09, 2025.
What is the P/E ratio for FibroBiologics stock?
The price to earnings (P/E) ratio for FibroBiologics (FBLG) stock is 0 as of August 09, 2025.
Does FibroBiologics stock pay dividends?
No, FibroBiologics (FBLG) stock does not pay dividends to its shareholders as of August 09, 2025.
When is the next FibroBiologics dividend payment date?
FibroBiologics (FBLG) stock does not pay dividends to its shareholders.
What is the beta indicator for FibroBiologics?
FibroBiologics (FBLG) does not currently have a Beta indicator.